Abstract:Background: Glucose perturbations can be detected by fasting plasma glucose (FPG), HbA1c, and the oral glucose tolerance test (OGTT). The highest yield is provided by OGTT. HbA1c is considered more practical. We compare the diagnostic and predictive performance of these glycaemic indicators based on combined data from the EUROASPIRE IV (EAIV) and V (EAV) studies. Methods: This cohort study was conducted in 79 centres in 24 European countries (EAIV) and 131 centres in 27 European countries (EAV). Eligible patients were aged 18-80 years, did not have diabetes, and were diagnosed with coronary artery disease 6-36 months (EAIV) or 6-24 months (EAV) before the investigation. Patients were investigated with OGTT (FPG and 2 h post-load glucose [2-hPG]) and HbA1c. Follow-up of subsequent cardiovascular events was done by means of a questionnaire at least 1 year after the baseline investigation. Analyses were done in patients with both OGTT and HbA1c data available. Outcome analysis in these patients was restricted to those with valid follow-up data available. Findings: 16 259 patients were interviewed in EAIV (2012-13) and EAV (2016-17). 8364 patients had both OGTT and HbA1C data and were included in the analysis population (3932 in EAIV and 4432 in EAV). Information on cardiovascular events was available in 7892 patients. Follow-up was for a median 1·6 years (IQR 1·2-2·0). The average patient age was 63·3 years (SD 9·8), and 6346 (75·9%) of 8364 patients were men. At baseline, 1856 (22·5%) of 8263 patients were determined to have newly detected type 2 diabetes using OGTT alone, compared with 346 (4·2%) using HbA1c alone. New dysglycaemia, defined as newly detected type 2 diabetes or impaired glucose tolerance (IGT), was present in 3896 (47·1%) of the patients according to 2hPG. 2hPG 9 mmol/L or greater (162 mg/dL, adjusted hazard ratio [aHR] 1·58; 95% CI 1·27-1·95, p<0·0001), and HbA1c 5·9% or greater (41 mmol/mol, aHR 1·48, 1·19-1·84; p=0·0010) were the strongest predictors of cardiovascular events, while FPG did not predict. A multivariable model showed that the effect of HbA1c on cardiovascular events was mainly explained by 2hPG (aHR for 1 unit increase in HbA1c 1·13, 0·98-1·30; p=0·11; and aHR for 1 unit increase in Ln[2hPG] 1·37, 1·08-1·74; p=0·0042). Interpretation: 2hPG appears better than HbA1c in detecting dysglycaemia and predicting its impact on future cardiovascular events in patients with coronary artery disease and should be recommended as the primary screening tool. Funding: Swedish Heart-Lung Foundation, Region Stockholm (ALF), the Erling Persson Foundation, the Baltic Child Foundation.

Early Diagnosis of T2DM Using High Sensitive Tests in the Mandatory Medical Examinations for Fishers, Seafarers and Other Transport Workers

Rethinking the Use of Urine Dipstick for Early Diagnosis of Type 2 Diabetes Mellitus.

SS48-04 SCREENING FOR TYPE 2 DIABETES AND HYPERTENSION IN SEAFARERS' MEDICAL EXAMINATIONS

Undiagnosed type 2 diabetes is common – intensified screening of established risk groups is imperative in Sweden: the SDPP cohort

Investigation of association of biomarkers of iron metabolism and insulin resistance in Egyptian patients with impaired glucose metabolism and type 2 diabetes

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus

Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies

Comparison of effect of different ways on screening type 2 diabetes Mellitus and DM related high-risk population

Assessment of 1-Hour Postload Plasma Glucose, the Metabolic Syndrome, and the Finish Diabetes Risk Score in the Prediction of Type 2 Diabetes

Early-stage Atherosclerosis in Newly Diagnosed, Untreated Type 2 Diabetes Mellitus and Impaired Glucose Tolerance

Identifying the unmet needs of individuals with Type 2 diabetes: an international web-based survey

Effects of a national checklist on recommended procedures among patients with type 2 diabetes

Diabetes case finding in the emergency department, using HbA1c: an opportunity to improve diabetes detection, prevention, and care

Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial

Early detection of type 2 diabetes risk: limitations of current diagnostic criteria

Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project

Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test

A simplified diagnostic work-up for the detection of gestational diabetes mellitus in low resources settings: achievements and challenges

The Clinical Significance of HbA1c Combined with Fasting Blood Glucose for Screening Glucose Metabolism Abnormality in High Risk Subjects of Type 2 Diabetes

A machine learning tool for identifying patients with newly diagnosed diabetes in primary care

Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study